Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
Date:3/3/2010

173,019 195,477 Deferred financing costs 11,409 11,363 Other assets 3,754 7,855 ------------------------------------------------------------------------- Total assets $ 370,059 $ 385,197 ------------------------------------------------------------------------- ------------------------------------------------------------------------- LIABILITIES AND SHAREHOLDERS' DEFICIT Current liabilities Accounts payable and accrued liabilities $ 46,324 $ 46,620 Income taxes payable 10,858 8,071 Interest payable on long-term debt 6,004 6,514 ------------------------------------------------------------------------- Total current liabilities 63,186 61,205 ------------------------------------------------------------------------- Deferred leasehold inducement 2,888 2,780 Deferred income taxes 36,778 40,577 Other tax liabilities 3,898 3,145 Long-term debt 575,000 575,000 Other liabilities 1,596 2,363 ------------------------------------------------------------------------- Total non-current liabilities 620,160 623,865 ------------------------------------------------------------------------- Shareholders' deficit Share capital Authorized: 200,000,000 Common shares, without par value 50,000,000 Class I Preference shares, without par value Common shares issued and outstanding: December 31, 2009 - 85,138,081 December 31, 2008 - 85,121,983 472,742 472,739 Additional p
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Angiotech Pharmaceuticals Announces Conference Call and Webcast
2. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
3. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
4. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
5. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
8. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
9. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
10. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
11. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
(Date:12/19/2014)... 2014 Egenix, Inc. is pleased to announce that ... the Board, to succeed Donald Fresne ; Mr. Fresne ... as a member of the Board.  In recognition of the ... company over almost twenty years, the Board designated Mr. Fresne ... has established a Search Committee to find a suitable replacement ...
(Date:12/17/2014)... 2014 “Never say, ‘I cannot ... Marburg’s Department of Physics, advises young women pursuing ... released SPIE Women in Optics 18-month planner ... to ask questions.” , In the annual planner, ... occupations ranging from university professor and laboratory researcher ...
(Date:12/17/2014)... Indianapolis, IN (PRWEB) December 17, 2014 ... for Laboratory Excellence following its most recent COLA ... Accreditation by COLA, a national healthcare accreditation organization. ... rigid standards of quality in day-to-day operations, demonstrate ... and pass a rigorous on-site laboratory survey. ...
Breaking Biology Technology:iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2
... Sept. 9 EnVivo Pharmaceuticals today announced the appointment of ... officer. DiPalma is responsible for overall financial operations for ... "EnVivo has grown to the point where we ... broad pipeline and increasing business opportunities," said Kees Been, CEO ...
... , DURHAM, N.C., Sept. 9 Oxygen Biotherapeutics, ... is being mailed today, asks shareholders to approve a 1-for-15 reverse ... , "At last years, general annual meeting we ... bulletin board and we promised to seek a listing change as ...
... , , , SAN DIEGO, Sept. 9 ... on the treatment of obesity, today announced that the Company will be speaking ... , , , Morgan Stanley Global Healthcare ... Time: 9:45am Eastern Time, Location: Grand Hyatt Hotel, ...
Cached Biology Technology:EnVivo Pharmaceuticals Names Stephen DiPalma Chief Financial Officer 2Oxygen Biotherapeutics, Inc. Seeks Shareholder Approval for Reverse Stock Split 2
(Date:12/19/2014)... DUBLIN , Dec. 18, 2014 Research and ... addition of the "Micro Market Monitor: North America ... http://photos.prnewswire.com/prnh/20130307/600769 ... grow at a CAGR of 3.6% from 2014 to ... in this market, Canada is ...
(Date:12/17/2014)... 15, 2014 Research and Markets ... the "Samsung Galaxy S5 - Home Button ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... sensing technology than the iPhone 5S, Samsung introduces ... its product. The Galaxy S5 home ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a leader ... PerformTek biometric technology to industry leaders such as Intel, ... clinically validated, biometric wearable products. These products will be ... Las Vegas . ... accurate, flexible and robust – with the clinical data ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... -- Studying animals in behavioral experiments has been a ... relevant for human behavior has been unclear. Weill Cornell ... DNA of a gene that imparts similar anxiety-related behavior ... can be accurately used to study these human behaviors. ...
... A major 7.0-magnitude earthquake struck the Haitian capital ... damage. The quake was followed by several aftershocks with ... make current maps suddenly out of date, causing additional ... satellite images can help rescue efforts by providing updated ...
... effects of climate change on the spread of infectious ... focus of a nearly $1.9 million grant from the ... a Penn State-led group of researchers. The grant is ... Recovery and Reinvestment Act. Climate change has the potential ...
Cached Biology News:Animal behavioral studies can mimic human behavior 2First satellite map of Haiti earthquake 2First satellite map of Haiti earthquake 3Stimulus grant to support research on climate and infectious disease 2
Rabbit Serum New Zealand or California Origin...
Collected from 8-12 week old New Zealand or Californian rabbits. Aseptically collected and processed to minimize hemolytic activity. Pricing: $60/unit for 1 - 10 units...
... Customer Peptide Synthesis , Containing one Phospho-Amino Acid ... returned to customer conjugation of peptide to KLH protein , ... 102 days/each , Pre-immune bleed x1 /each ... Test bleed (app. 5 ml) x1 /each ...
... is collected off the clot fasted non-Swiss Albino mice ... Available Anticoagulants: N-02: Citrate N-04: ... Potassium Oxalate N-10: EDTA (Na) ... CPD N-09: K3EDTA N-11: ...
Biology Products: